Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 5,188,000 | 5,150,000 | 5,170,000 | 4,897,000 | 5,356,000 |
| Cost of Goods | 2,206,000 | 2,242,000 | 2,218,000 | 2,081,000 | 2,337,000 |
| Gross Profit | 2,982,000 | 2,908,000 | 2,952,000 | 2,816,000 | 3,019,000 |
| Operating Expenses | 2,167,000 | 2,195,000 | 2,223,000 | 2,206,000 | 2,190,000 |
| Operating Income | 815,000 | 713,000 | 729,000 | 610,000 | 829,000 |
| Interest Expense | 41,000 | 41,000 | 44,000 | 37,000 | 43,000 |
| Other Income | 56,000 | 42,000 | 301,000 | 80,000 | 18,000 |
| Pre-tax Income | 830,000 | 714,000 | 986,000 | 653,000 | 804,000 |
| Income Tax | 135,000 | 118,000 | 200,000 | 124,000 | 170,000 |
| Net Income Continuous | 695,000 | 596,000 | 786,000 | 529,000 | 634,000 |
| Net Income Discontinuous | 72,000 | -16,000 | -2,000 | 1,763,000 | 271,000 |
| Net Income | $767,000 | $580,000 | $784,000 | $2,292,000 | $905,000 |
| EPS Basic Total Ops | 0.51 | 0.39 | 0.52 | 1.52 | 0.59 |
| EPS Basic Continuous Ops | 0.46 | 0.40 | 0.52 | 0.35 | 0.42 |
| EPS Basic Discontinuous Ops | 0.05 | -0.01 | 0.00 | 1.17 | 0.17 |
| EPS Diluted Total Ops | 0.51 | 0.38 | 0.52 | 1.51 | 0.59 |
| EPS Diluted Continuous Ops | 0.46 | 0.39 | 0.52 | 0.35 | 0.41 |
| EPS Diluted Discontinuous Ops | 0.05 | -0.01 | 0.00 | 1.16 | 0.18 |
| EBITDA(a) | $1,181,000 | $1,096,000 | $1,081,000 | $981,000 | $1,224,000 |